[{"Assets_0_Q2_USD":"2412149000.0","CIK":"874716","CommonStockSharesIssued_0_Q2_shares":"106748000.0","CommonStockSharesOutstanding_0_Q2_shares":"85096000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"2.37","EarningsPerShareBasic_2_Q2_USD":"4.76","EarningsPerShareDiluted_1_Q2_USD":"2.34","EarningsPerShareDiluted_2_Q2_USD":"4.69","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","MinorityInterest_0_Q2_USD":"763000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"358377000.0","NetIncomeLoss_1_Q2_USD":"202582000.0","NetIncomeLoss_2_Q2_USD":"406839000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q2_USD":"202606000.0","ProfitLoss_2_Q2_USD":"406895000.0","RevenuesConverted_1_Q2_USD":"826142000.0","RevenuesConverted_2_Q2_USD":"1603849000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"748223000.0","StockholdersEquity_0_Q2_USD":"747460000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q2_shares":"21653000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"86654000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"86794000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"85325000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"85427000.0","filed":"20210730","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"IDEXX LABORATORIES INC \/DE","period":"20210630","qtrs":"1","uom":"USD"}]